346 results on '"Zhou, Xiao-Jian"'
Search Results
2. Two New Anthraquinones from the Marine-Derived Fungus Fusarium sp. J3-2
3. THU-382 Lead-in cohort results from a phase 2 study of a novel 8-week combination regimen of Bemnifosbuvir and Ruzasvir in patients with chronic hepatitis C virus infection
4. First-in-human trial evaluating safety and pharmacokinetics of AT-752, a novel nucleotide prodrug with pan-serotype activity against dengue virus
5. Regioselective and enantioselective propargylic hydroxylations catalyzed by P450tol monooxygenases
6. Human bronchopulmonary disposition and plasma pharmacokinetics of oral bemnifosbuvir (AT-527), an experimental guanosine nucleotide prodrug for COVID-19.
7. Bemnifosbuvir (BEM, AT-527), a novel nucleotide analogue inhibitor of the hepatitis C virus NS5B polymerase
8. Human bronchopulmonary disposition and plasma pharmacokinetics of oral bemnifosbuvir (AT-527), an experimental guanosine nucleotide prodrug for COVID-19
9. Enantiodivergent Synthesis of Halohydrins by Engineering P450DA Monooxygenases
10. Bioactive Indole Diterpenoids and Polyketides from the Marine-Derived Fungus Penicillium javanicum
11. Road traffic bottleneck analysis for expressway for safety under disaster events using blockchain machine learning
12. Oral bemnifosbuvir (AT-527) vs placebo in patients with mild-to-moderate COVID-19 in an outpatient setting (MORNINGSKY)
13. Investigation of radioactive level of drinking water sources in the Upper Yangtze River of Chongqing city
14. Impact of Aspen Strand Size on Oriented Strand Board Properties.
15. The relationship between vitamin D levels in umbilical cord blood and infantile eczema
16. Radiation protection in the design of γ-ray industrial computed tomography systems
17. Enhancing Least Square Support Vector Regression with Gradient Information
18. Highly Enantioselective Hydroxylation of 3-Arylpropanenitriles to Access Chiral β-Hydroxy Nitriles by Engineering of P450pyr Monooxygenase
19. Organocatalyzed asymmetric dearomative 1,3‐dipolar cycloaddition of 2‐nitrobenzofurans and N‐2,2,2‐trifluoroethylisatin ketimines
20. Directed evolution of cytochrome P450DA hydroxylase activity for stereoselective biohydroxylation
21. Efficacy and safety of salmeterol/fluticasone compared with montelukast alone (or add-on therapy to fluticasone) in the treatment of bronchial asthma in children and adolescents
22. Metastasis-associated genes in oral squamous cell carcinoma and salivary adenoid cystic carcinoma: a differential DNA chip analysis between metastatic and nonmetastatic cell systems
23. Brain-targeting research of 10-O-nicotinate ginkgolide B: a new prodrug of ginkgolide B
24. Ganciclovir Treatment of Symptomatic Congenital Cytomegalovirus Infection: Results of a Phase II Study
25. Ensemble of surrogates with recursive arithmetic average
26. AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 In Vitro and a Promising Oral Antiviral for Treatment of COVID-19
27. 5-(Phenylthio)acyclouridine: a powerful enhancer of oral uridine bioavailability: relevance to chemotherapy with 5-fluorouracil and other uridine rescue regimens
28. Single-dose and multiple-dose pharmacokinetics and safety of telbivudine after oral administration in healthy Chinese subjects
29. Absence of food effect on the pharmacokinetics of telbivudine following oral administration in healthy subjects
30. Enhancement of the bioavailability of oral uridine by coadministration of 5-(phenylthio)acyclouridine, a uridine phosphorylase inhibitor: implications for uridine rescue regimens in chemotherapy
31. Modulation of the pharmacokinetics of endogenous plasma uridine by 5-(phenylthio)acyclouridine, a uridine phosphorylase inhibitor: implications for chemotherapy
32. Simultaneous quantitation of the 5′-triphosphate metabolites of zidovudine, lamivudine, and stavudine in peripheral mononuclear blood cells of HIV infected patients by high-performance liquid chromatography tandem mass spectrometry
33. Phase I dose escalation pharmacokinetics of O-(chloroacetylcarbamoyl) fumagillol (TNP-470) and its metabolites in AIDS patients with Kaposi's sarcoma
34. High Rates of Rapid Virologic Response (RVR) and Complete Early Virologic Response (cEVR) with IDX184, Pegylated Interferon and Ribavirin in Genotype 1 HCVInfected Subjects: Interim Results: 1748
35. Drug interaction profile for GSK2248761, a next generation non-nucleoside reverse transcriptase inhibitor
36. [Untitled]Three-dimensional finite element model of the distal humerus and the related biomechanics analysis
37. [Untitled]Three-dimensional finite element model of the distal humerus and the related biomechanics analysis
38. 1265. AT-527, an Oral Purine Nucleotide Prodrug Exhibiting Potent In Vitro Antiviral Activity Against Human Coronaviruses, Including SARS-CoV-2
39. 169. AT-752, an Oral Guanosine Nucleotide Prodrug, Exhibits Potent in Vitro Activity Against Flaviviruses and Prevents Disease Progression in a Dengue Mouse Model
40. Catalytic Enantioselective Dearomatization/Rearomatization of 2-Nitroindoles to Access 3-Indolyl-3′-Aryl-/Alkyloxindoles: Application in the Formal Synthesis of Cyclotryptamine Alkaloids
41. A combination of AT-527, a pan-genotypic guanosine nucleotide prodrug, and daclatasvir was well-tolerated and effective in HCV-infected subjects
42. Genetic structure, gene flow pattern, and association analysis of superior germplasm resources in domesticated upland cotton (Gossypium hirsutum L.)
43. Preclinical evaluation of AT-527, a novel guanosine nucleotide prodrug with potent, pan-genotypic activity against hepatitis C virus
44. Corrigendum to “Methods for analyzing road network bottleneck and bottleneck chain corridor under disastrous events using graph theory” [Saf. Sci. 118 (2019) 925–932]
45. Safety, Pharmacokinetics, and Antiviral Activity of AT-527, a Novel Purine Nucleotide Prodrug, in Hepatitis C Virus-Infected Subjects with or without Cirrhosis
46. Synergistic down-regulation of telomerase by all-trans retinoic acid and antisense oligonucleotide in oral squamous cell carcinoma cell line (Tca8113)
47. Population Pharmacokinetics of Telbivudine and Determination of Dose Adjustment for Patients With Renal Impairment
48. Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma
49. Absence of Effect of Telbivudine on Cardiac Repolarization: Results of a Thorough QT/QTc Study in Healthy Participants
50. Microdose Pharmacokinetics of IDX899 and IDX989, Candidate HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors, Following Oral and Intravenous Administration in Healthy Male Subjects
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.